A Phase 2, Single Arm, European Multi-center Trial Evaluating the Efficacy of Afatinib as First-line or Later-line Treatment in Advanced Chordoma.
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2018
At a glance
- Drugs Afatinib (Primary)
- Indications Chordoma
- Focus Therapeutic Use
- 06 Jul 2018 Status changed from not yet recruiting to recruiting.
- 12 Jan 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Mar 2019.
- 12 Jan 2018 Planned initiation date changed from 1 Oct 2017 to 1 Mar 2018.